Emmaus Life Sciences, Inc.
EMMA · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,076 | -$1,135 | -$2,330 | -$1,748 |
| Dep. & Amort. | $15 | $4 | $5 | $5 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $9 | -$1 | $10 | $29 |
| Change in WC | $0 | -$1,265 | $2,343 | $2,720 |
| Other Non-Cash | $2,461 | -$511 | $251 | -$663 |
| Operating Cash Flow | $409 | -$2,908 | $279 | $343 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$1 | $0 | -$6 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $2,172 | $0 | $4 |
| Investing Cash Flow | $0 | $2,171 | $0 | -$2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $284 | -$345 | -$195 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,002 | $0 | $0 | $0 |
| Financing Cash Flow | -$1,002 | $284 | -$345 | -$195 |
| Forex Effect | $1 | $5 | $10 | -$12 |
| Net Chg. in Cash | -$592 | -$448 | -$56 | $134 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $885 | $1,333 | $1,389 | $1,255 |
| End Cash | $293 | $885 | $1,333 | $1,389 |
| Free Cash Flow | $409 | -$2,909 | $279 | $337 |